~" By conventional criteria, an apneic patient's PaCO2 must be greater than 60 mm Hg before apnea can be attributed to brain death. The rate of a PaCO2 increase in the apneic patient traditionally has been thought to be in the range of 3 mm Hg/min. In order to assess the validity of these data and the validity of the "apnea test" for determination of brain death, the results of this test were reviewed in 20 patients. In all patients, arterial blood samples were drawn for blood gas measurements every 2 minutes following the cessation of volume ventilation (with an oxygen cannula at 6 liters O2/min passed into the tracheobronchial tree).
N EUROLOGISTS and neurosurgeons approach the diagnosis of brain death from a variety of moral, medical, and emotional standpoints. J. 2 The method of apnea testing is likewise highly variable. 2 The "apnea test" for the determination of brain death has frequently been inadequately defined and inconsistently performed. In order to assess a commonly used approach to the apnea test, a prospective analysis was done on 20 consecutive patients whose brain-death determination criteria were completed with a positive apnea test at the Louisiana State University Medical Center during a 1-year period ending in February, 1988.
Clinical Material and Methods
Twenty consecutive patients who met the neurological criteria for brain death underwent apnea testing as the final aspect of their brain-death determination pro-cedure during a 1-year period ending in February, 1988. There were 12 males and eight females. Thirteen were black, six were white, and one was oriental. The average age was 35 years (range 44 months to 86 years,) Two patients each had a pulmonary contusion and pulmonary edema. One patient each had pneumonia, a history of chronic obstructive pulmonary disease, and a cardiac contusion. Other electrocardiographic or cardiac auscultatory findings included left ventricular hypertrophy (three cases), a bundle branch block (three cases), mitral valve prolapse (two cases), and aortic insufficiency (one case). The etiology of the neurological injury was severe closed head injury in six patients, gunshot wound to the head in four, subarachnoid hemorrhage in four, hypertensive intracerebral hemorrhage in three, hypoxic encephalopathy in two, and acute subdural hematoma in one patient. All twenty patients underwent a standard protocol for the apnea test.
Each patient had an arterial blood sample drawn for baseline blood gas determination using a previously placed arterial line while receiving respiratory support from a volume ventilator. The patients were then withdrawn from ventilatory support. Immediately, an oxygen cannula (No. 14 French tracheal suction catheter with the side port covered with adhesive tape) was passed into the endotracheal tube or tracheostomy tube to the estimated location of the carina tracheae. Oxygen at 6 liters/min was infused through the catheter. Arterial blood samples were then drawn every 2 minutes until a PaCO2 of m o r e than 60 m m Hg was obtained or the patient breathed spontaneously (no patients in this series developed spontaneous respirations).
Results
The m e a n core temperature of the patients in this series was 98.4"F (range 97* to 101*F). The m e a n heart rate was 93 beats/min (range 70 to 110 beats/min). The average m e a n arterial blood pressure was 80 m m Hg. The patients in this series fell into two distinct categories on the basis of their baseline PaCO2 and the response of their PaCO2 to apnea: those whose baseline PaCO2 was 30 m m Hg or less (Group 1) and those whose baseline PaCO2 was greater than 30 m m Hg (Group 2).
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This division allowed a series of observations to be m a d e in hypocapneic (Group 1) and normocapneic (Group 2) patients.
The average rate o f rise or fall of PaCO2, PaO2, and arterial p H is depicted in Table 1 . This information is broken down by time segments; 0 to 4, 4 to 8, and 8 to 12 minutes following the beginning of the test. The rates of change of PaCO2 and arterial p H were noted to be similar in both groups ( Figs. 1 and 2) . The average rate of PaCO2 increase was 3.7 ___ 2.3 m m Hg/min; however, it initially rose rapidly. The rate of rise fell off at 4 minutes in both groups (Table 1 ). In fact, the average rate of PaCOz increase after 12 minutes (for patients whose PaCO2 had not yet reached 60 m m Hg) was 0.92 m m Hg/min. Figure 3 illustrates this p h e n o menon. Patients whose tests lasted longer than 12 minutes m a y linger, with a PaCOz approaching 60 m m Hg at a m u c h slower rate, thus skewing the results. In these few patients, the PaCO2 approached 60 m m Hg in a nearly asymptotic manner. The apnea test for determining brain death Figure 4 illustrates the change of PaOz with respect to time. Three patients were not adequately oxygenated throughout the entire test (PaO2 < 50 mm Hg at the end of the test); however, this is not reflected in the average PaO2 (Table 1 ) nor in Fig. 4 . None of the factors observed in this series correlated with the failure to maintain an adequate PaO2 in these three patients.
Electrocardiographic alterations were noted in only two patients. Both patients had occasional premature ventricular contractions. No hypotension, bradycardia, or other manifestation of myocardial injury was noted. In spite of the fact that 50% of the patients had a premorbid underlying cardiac abnormality, there were no significant cardiac arrhythmias arising during the apnea test.
No correlation between the presence or absence of cardiac respirations (an audible movement of air, elicited by listening at the tracheostomy or endotracheal tube orifice, which is in synchrony with the heart beat) with the parameters studied was noted. Likewise, no 80-E E 0 a. correlations between the presence or absence of pneumonia or congestive heart failure and the other parameters studied were observed.
Discussion
A standardized apnea test for the determination of brain death offers several advantages. First, the achievement of an adequate drive for respiration (PaCO2 > 50 to 60 mm Hg) 4' 5~7' 9 is consistently documented in an efficient, accurate, and rapid manner. Second, an appropriate test helps minimize the incidence of hypoxia, which may cause irreversible cardiovascular complications, injury to the central nervous system in patients who are not brain dead, or injury to transplantable organs in brain-dead patients? -7 Third, it offers a standardized approach with which one patient's test could be compared and contrasted with that of another.
It was observed that the rise of PaCO2 after the onset of apnea follows a similar course regardless of the baseline PaCOz. The initial rate of rise is rapid, followed by a slower rate of increase. This phenomenon has been observed previously? Since the curves obtained by plotting PaCOz against time for Group 1 and 2 patients are parallel, the only factor altering the time required to achieve a PaCO2 of 60 mm Hg (other than uncontrollable variables such as the presence of pneumonia) is the baseline PaCO2.
Others have recommended starting the apnea test at a normocarbic baseline PACO2.5'6 A high baseline PaCO2 is significant even if the rate of PaCOz increase is linear. The erratic and nonlinear relationship between the rate of PaCO2 increase and time, noted here and by others, 7-9 magnifies even further the significance of the apnea test performed with a high baseline PaCO2. The PaCO2 of several patients whose baseline PaCO2 was low, asymptotically approached 60 mm Hg with an accompanying significantly prolonged duration of the apnea test.
Three patients in this series did not maintain adequate oxygenation throughout the entire duration of the test (PaO2 < 50 mm Hg); however, there were no factors that appeared to causally relate to this phenomenon. Therefore, no further precautions could be taken to prevent hypoxia during the test other than shortening it by starting with a higher PaCO2.
In order to improve the efficiency and safety of the apnea test, a slight revision is recommended. A 1.0 fraction of inspired oxygen is administered for at least 15 minutes prior to the initiation of the test. Manipulations of the respiratory rate and tidal volume are performed as needed in order to raise the PaCO2 to greater than 40 mm Hg. Blood gas determinations confirm this, as well as adequate oxygenation (PaO2 > 150 mm Hg), prior to the commencement of the test. Following the discontinuation of volume ventilation and the endotracheal placement of the oxygen cannula (flowing at 6 liters O2/min), arterial blood samples are drawn every 2 minutes until either a PaCO2 of 60 mm Hg is achieved, the patient breathes, cardiovascular instability occurs, or a significant drop in arterial oxygen saturation is observed (< 80%).
In summary, a standardized apnea test is presented which offers several advantages over previously employed techniques. It allows a rapid, safe, and simple method of determining the presence of apnea secondary to brain death. The observation that a high baseline PaCO_~ greatly augments the efficiency and safety of the test allows criteria that have previously been based upon conjecture to be documented and applied clinically. A standardized apnea test, utilizing these principles, may satisfy many of the criticisms regarding brain-death testing raised by neurologists, neurosurgeons, and transplant surgeons.
